On Dec. 16, 2014, the National Health and Family Planning Commission (NHFPC) of China notified the World Health Organization (WHO) of 11 additional laboratory-confirmed cases of human infection with avian influenza A(H7N9) virus, including five deaths.
Details of the cases are as follows:
A 75-year-old male from Yancheng City, Jiangsu Province wdeveloped symptoms on Nov. 11. The patient was admitted to hospital on Nov. 14 but died on Nov. 25. The patient had a history of exposure to live poultry.
A 68-year-old male from Urumqi City, Xinjiang Uyghur Autonomous Region developed symptoms on Nov. 14. The patient was admitted to a hospital on Nov. 21 but died on Nov. 24. The patient had a history of exposure to live poultry.
A 45-year-old male from Shihezi City, Xinjiang Uyghur Autonomous Region developed symptoms on Nov. 15. The patient was admitted to hospital on Nov. 19 but died on Nov. 27. The patient had a history of exposure to live poultry.
A 59-year-old female from Jiaxing City, Zhejiang Province developed symptoms on Nov. 17. The patient was admitted to a hospital on Nov. 22 and is now in severe condition. The patient has a history of exposure to live poultry.
A 31-year-old female from Dongguan City, Guangdong Province developed symptoms on Nov. 22. The patient was admitted to a hospital on Nov. 25 and is now in severe condition. The patient has a history of exposure to live poultry.
An 81-year-old female from Urumqi City, Xinjiang Uyghur Autonomous Region developed symptoms on Nov. 24. The patient was admitted to a hospital on Nov. 27 but died on Dec. 1. The patient had a history of exposure to live poultry.
A 66-year-old male from Meizhou City, Guangdong Province developed symptoms on Nov. 25. The patient was admitted to a hospital on Nov. 27 but died on Dec. 3. The patient had a history of exposure to live poultry.
A 36-year-old male from Jinhua City, Zhejiang Province developed symptoms on Nov. 26. The patient did not require hospitalization and is now in mild condition. The patient has a history of exposure to live poultry.
A 27-year-old male from Fuzhou City, Fujian Province developed symptoms on Nov. 26. The patient was admitted to a hospital on Dec. 1 and is now in severe condition. The patient has a history of exposure to live poultry.
A 38-year-old male from Minghang District, Shanghai City developed symptoms on Nov. 28. The patient was admitted to a hospital on Dec. 1 and is now in severe condition. The patient has a history of exposure to live poultry.
A 65-year-old male from Changji Hui Autonomous Prefecture, Xinjiang Uyghur Autonomous Region developed symptoms on Dec. 1. The patient was admitted to a hospital on Dec. 1 and is now in severe condition. The patient did not recall a history of direct exposure to live poultry.
The Chinese government has taken the following surveillance and control measures: Strengthen surveillance and situation analysis; reinforce case management and medical treatment; and onduct risk communication with the public and release information.
WHO continues to closely monitor the H7N9 situation and conduct risk assessment. So far, the overall risk associated with the H7N9 virus has not changed.
WHO advises that travelers to countries with known outbreaks of avian influenza should avoid poultry farms, or contact with animals in live bird markets, or entering areas where poultry may be slaughtered, or contact with any surfaces that appear to be contaminated with feces from poultry or other animals. Travellers should also wash their hands often with soap and water. Travelers should follow good food safety and good food hygiene practices.
WHO does not advise special screening at points of entry with regard to this event, nor does it currently recommend any travel or trade restrictions. As always, a diagnosis of infection with an avian influenza virus should be considered in individuals who develop severe acute respiratory symptoms while travelling or soon after returning from an area where avian influenza is a concern.
WHO encourages countries to continue strengthening influenza surveillance, including surveillance for severe acute respiratory infections (SARI) and to carefully review any unusual patterns, in order to ensure reporting of human infections under the IHR (2005), and continue national health preparedness actions.
Source: WHO
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.